ArticleExploration (Beijing, China)2026
Electrochemical Valence-Regulated Biomimetic Nanozymes for Breast Cancer Metabolism Inhibition and Potentiated Catalytic Immunotherapy.
You Pan, Wei Cai, Meng Suo, Xiangqin Meng, Shengxin Ye, Yuping Tan, Xianqing Wei, Mingpu Yang, Pengyuan Qi, Zihang Yu and 2 more
Abstract read
In one paragraphArticle in Exploration (Beijing, China), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
You Pan *Department of Breast Surgery The Second Affiliated Hospital of Guangxi Medical University Nanning China.
Wei Cai *Department of Radiology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan China.
Meng Suo *Research Centers of Nanomedicine Technology & Clinical Medicine The Second Affiliated Hospital of Guangxi Medical University Nanning China.
Xiangqin Meng *CAS Engineering Laboratory For Nanozyme State Key Laboratory of Biomacromolecules Institute of Biophysics Chinese Academy of Sciences Beijing China.
Shengxin YeResearch Centers of Nanomedicine Technology & Clinical Medicine The Second Affiliated Hospital of Guangxi Medical University Nanning China.
Yuping TanResearch Centers of Nanomedicine Technology & Clinical Medicine The Second Affiliated Hospital of Guangxi Medical University Nanning China.
Xianqing WeiResearch Centers of Nanomedicine Technology & Clinical Medicine The Second Affiliated Hospital of Guangxi Medical University Nanning China.
Mingpu YangResearch Centers of Nanomedicine Technology & Clinical Medicine The Second Affiliated Hospital of Guangxi Medical University Nanning China.
Pengyuan QiCancer Center Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan China.
Zihang YuDepartment of Biomedical Engineering Columbia University New York City New York USA.
Kelong FanCAS Engineering Laboratory For Nanozyme State Key Laboratory of Biomacromolecules Institute of Biophysics Chinese Academy of Sciences Beijing China.
Shipeng NingDepartment of Breast Surgery The Second Affiliated Hospital of Guangxi Medical University Nanning China.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Indexed as
biomimetic MnOx nanozymescatalytic immunotherapycGAS‐STING pathwayelectrochemical valence regulationPD‐L1 antagonist
Identifiers
PMID42761336
PMCPMC13586063
What OpenQuestion holds
Textmetadata
Read underepoch 390